The FDA granted Fast Track designation to custirsen when given in combination with cabazitaxel/prednisone for the treatment of metastatic castration-resistant prostate cancer (mCRPC) after prior treatment with a docetaxel-containing regimen.
The FDA has granted Orphan Drug designation to alvocidib for the treatment of patients with acute myeloid leukemia.
Rates of esophageal squamous cell carcinoma (ESCC) nearly double for those who use tobacco and consume alcohol, compared to individuals who only smoke or drink.
Resistance to initial therapy for patients with CLL may limit treatment options; however, rituximab combined with the PI3K inhibitor idelalisib may offer a tolerable alternative therapy.
Reversing obesity may also reduce a woman's chance of developing uterine cancer.
R.M. is a 58-year-old male recently diagnosed with stage IV pancreatic adenocarcinoma (Slide 1). He is a mechanical engineer ...
J.W. is a 55-year-old woman recently admitted to the hospital for worsening shortness of breath (Slide 1).
Relevant Medical History
Editorial Board Member Don Dizon, MD, answers some questions about issues in breast cancer treatment today.
ChemotherapyAdvisor.com Editorial Board Member Don S. Dizon discusses survivorship issues from the 2013 Breast Cancer Symposium.
Barbara Ann Burtness, MD
Steven Cohen, MD
E. David Crawford, MD
Don S. Dizon, MD, FACP
Jeffrey M. Farma, MD
Edith A. Perez, MD
Neal D. Shore, MD, FACS
Mark A. Socinski, MD
Martin Tallman, MD
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|